pocketful logo
Aspira Pathlab & Diagnostics Ltd logo

Aspira Pathlab & Diagnostics Ltd

NSE: BSE: 540788

55.85

(2.01%)

Sun, 05 Apr 2026, 07:29 am

Aspira Pathlab & Diagnostics Share Price Live Chart

1 Day

0 (0%)

No Result Found

Summary

  • Market Cap

    59.77

  • Net Profit

    2.02

  • P/B

    12.12

  • Sector P/E

    53.07

  • P/E

    43.26

  • EV/EBITDA

    22.66

  • Debt/Equity (Industry)

    0.18

  • Interest Cover (Industry)

    12.13

  • ROCE (Industry)

    17.76

  • RONW (Industry)

    14.92

  • ROE

    16.47

  • ROCE

    11.47

  • Debt/Equity

    0.15

  • EPS (TTM)

    2.33

  • Dividend Yield

    0

  • Book Value

    7.03

  • Interest Cover

    6.77

Analysis

all

thumbs up icon

Pros

  • Aspira Pathlab & Diagnostics has no debt, it does not need to be covered by operating cash flow.
  • Aspira Pathlab & Diagnostics has no debt, it does not need to be covered by short term assets.
  • Aspira Pathlab & Diagnostics has not taken on any debt in the past 5 years.
  • Aspira Pathlab & Diagnostics has no debt, therefore coverage of interest payments is not a concern.
  • Aspira Pathlab & Diagnostics has no debt.
thumbs up icon

Cons

  • Unable to evaluate Aspira Pathlab & Diagnostics's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate Aspira Pathlab & Diagnostics's dividend against the top 25% market benchmark as the company has not reported any payouts.
  • Aspira Pathlab & Diagnostics is not covered by any analysts.
  • BSE:540788 has not traded for 89 days.
  • BSE:540788 is flat (0%) underperforming the Healthcare industry which returned 7% over the past month.

Read More

Financials

Read More

Ratios

Read More

Shareholding

ShareholdersDEC 2025SEPT 2025JUN 2025MAR 2025DEC 2024
Promoters18.3918.3918.3918.3918.55
FII00000
DII00000
Public81.6181.6181.6181.6181.45
Government00000

Read More

Technical Analysis

RSI

50.86

MACD

-0.86

50 DMA

60.08

200 DMA

61.92

Support and Resistance

TypeR3R2R1PPS1S2S3
Classic99.4179.3767.6159.3347.5739.2919.25
Fibonacci79.3771.7166.9959.3351.6746.9539.29
Camarilla61.3659.5257.6959.3354.0152.1850.34

Pivots Level: Classic

R3

+40.08

99.41

R2

+20.04

79.37

R1

+8.28

67.61

59.33
59.33
Pivot Point
LTP: 58.07

S1

-11.76

47.57

S2

-20.04

39.29

S3

-40.08

19.25

Moving Average

SMAEMA

Period

Value

  • 10-EMA

    56.69

  • 20-EMA

    57.08

  • 30-EMA

    57.86

  • 50-EMA

    59.25

  • 100-EMA

    61.03

  • 200-EMA

    61.58

Read More

Corporate Actions

Announcement DatePurposeActionEx Date
10 Feb 2026board-meetingsQuarterly Results
29 Aug 2025agm
27 Aug 2024agm
16 Aug 2023agm
18 Aug 2022agm
18 Aug 2021agm

Read More

Peer Comparison

Aspira Pathlab & Diagnostics Ltd logo

Aspira Pathlab & Diagnostics Ltd

Max Healthcare Institute Ltd logo

Max Healthcare Institute Ltd

Narayana Hrudayalaya Ltd logo

Narayana Hrudayalaya Ltd

Aster DM Healthcare Ltd logo

Aster DM Healthcare Ltd

Apollo Hospitals Enterprise Ltd logo

Apollo Hospitals Enterprise Ltd

Fortis Healthcare Ltd logo

Fortis Healthcare Ltd

Read More

Aspira Pathlab & Diagnostics Ltd About

Aspira Pathlab & Diagnostics is engaged in the business of running, owning, managing and administering Diagnostics Centres. The principal activities of the Company consist of pathology investigation services, radiology investigation services and other related healthcare services at Diagnostic Centres in Mumbai.

Industry

Healthcare

Founded

1973

Headquarters

CEO

Haseeb A Drabu

Employees

Contact

Website icon

Website

http://www.aspiradiagnostics.com

Email icon

Email

info@aspiradiagnostics.com

Phone icon

Phone

91-22-71975756/5656

Location icon

Location

Flat No. 2 RD Shah Building, Shraddanand Road Ghatkopar(W), Mumbai, Maharashtra, 400086

Read More

Aspira Pathlab & Diagnostics Ltd Company History

YearHistory
1973
  • The company was incorporated as 'Industrial Gas & Steel Products (India) Ltd.' on 3rd July.
1980
  • The Company changed its name to 'Utkal Soap Products Ltd.' on 4th February.
  • The Company changed its object to manufacture laundry soaps for Hindustan Lever Limited.
2004
  • The Company stopped manufacturing production in November.
2005
  • The Company disposed off all its assets.
  • The Company stopped manufacturing production in November 2004 and the employees have been paid off their dues as per settlement with the Labour union since 2005.
2016
  • The Company changed its object clause on 10th August.
  • The Company changed its name to 'Aspira Pathlab & Diagnostics Ltd.' on 16th November.
  • The Company started generating income from diagnostic centers and laboratories in December.

Read More

Deals

Client NameOrder SideQTYAvg PriceDate
DIVYA KANDABuy5213059.5609 Oct 2025
DIVYA KANDASell1472161.9709 Oct 2025
DEVJI DEYAT NANDASell9000075.2606 Oct 2025
ADEQUATE REAL TRADE LLPBuy7200058.9925 Aug 2025
RAJESH PREMJI BHANUSHALIBuy6868228.3402 Jul 2024
SOCRADAMUS CAPITAL PRIVATE LIMITED .Sell12500028.8502 Jul 2024
GLORIOUS HOLDINGS PVT LTDSell750003028 Jun 2024
DEVJI DEYAT NANDABuy6900925.125 Jun 2024
GLORIOUS HOLDINGS PVT LTDSell8400025.1625 Jun 2024
GLORIOUS HOLDINGS PVT LTDSell6000025.6424 Jun 2024

Read More

Aspira Pathlab & Diagnostics Ltd News

Aspira Pathlab Open Offer Record Date Set March 27

Aspira Pathlab & Diagnostics Limited fixes March 27, 2026 as record date for open offer of 26,76,180 equity shares at ₹55 per share by five acquirers under SEBI takeover regulations.

25 Mar 2026

companies

Aspira Pathlab Company Secretary Resigns

Aspira Pathlab & Diagnostics announces resignation of Company Secretary cum Compliance Officer Ms. Krupali Shah due to personal reasons, effective March 08, 2026.

07 Mar 2026

stocks

Aspira Pathlab Reports Q3FY26 Loss of ₹156.12 Lakhs

Aspira Pathlab & Diagnostics Limited reported a net loss of ₹156.12 lakhs for Q3FY26, compared to profit of ₹37.66 lakhs in Q3FY25. Nine-month profit declined to ₹74.03 lakhs from ₹135.02 lakhs year-on-year.

10 Feb 2026

co actions results

Aspira Pathlab Submits Q3FY26 Compliance Certificate

Aspira Pathlab & Diagnostics Limited has submitted its quarterly compliance certificate under SEBI regulations for the quarter ended December 31, 2025, confirming proper dematerialisation processes.

07 Jan 2026

stocks

Aspira Pathlab Independent Director Dr. Deshpande Dies

Aspira Pathlab & Diagnostics Limited announces the demise of Independent Director Dr. Alaka Keshav Deshpande, aged 79, who passed away on December 30, 2025. She served on multiple board committees.

02 Jan 2026

stocks

Read More

Open Your Free Demat Account Now!

Step into a world of zero fees and limitless opportunities!

pocketful logo

2022-25 Pocketful. All rights reserved, Built with in India

Version -5.76

app image 1app image 2

Explore

Calculatorsfooter arrow down icon
Popular Calculatorsfooter arrow down icon
Group Stocksfooter arrow down icon

Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800